UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A
Cellular & molecular immunology, ISSN 1672-7681, 01/2016, Volume 13, Issue 1, pp. 94 - 102
IFNα | HCV | NS5A | TRIM22 | ubiquitin | Life Sciences & Biomedicine | Immunology | Science & Technology | RNA, Small Interfering - genetics | Hepatitis C, Chronic - pathology | Hepacivirus - immunology | Minor Histocompatibility Antigens | Humans | Hepatitis C, Chronic - virology | Repressor Proteins - antagonists & inhibitors | Viral Load | Tripartite Motif Proteins | Proteolysis - drug effects | Ubiquitination - drug effects | Interferon-alpha - genetics | HEK293 Cells | Hepatocytes - drug effects | Viral Nonstructural Proteins - immunology | Hepacivirus - drug effects | Virus Replication - drug effects | Signal Transduction | Gene Expression Regulation | Interferon-alpha - therapeutic use | Repressor Proteins - genetics | Viral Nonstructural Proteins - genetics | Repressor Proteins - agonists | Hepatitis C, Chronic - drug therapy | Hepatocytes - immunology | Interferon-alpha - immunology | Host-Pathogen Interactions | Repressor Proteins - immunology | Hepatitis C, Chronic - immunology | Cell Line, Tumor | Hepatocytes - virology | Hepacivirus - growth & development | RNA, Small Interfering - metabolism | Index Medicus
Journal Article
Chinese medical journal, ISSN 0366-6999, 2020, Volume 133, Issue 9, pp. 1132 - 1134
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pandemics | Ritonavir - administration & dosage | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Antiviral Agents - administration & dosage | Randomized Controlled Trials as Topic | COVID-19 | Interferon-alpha - administration & dosage | SARS-CoV-2 | Ribavirin - administration & dosage | Betacoronavirus | Lopinavir - administration & dosage | Adult | Aged | Drug Therapy, Combination | Interferon | Coronaviruses | Middle East respiratory syndrome | Index Medicus | Correspondence
Journal Article
Journal of virology, ISSN 0022-538X, 02/2019, Volume 93, Issue 3
HIV-1 | NK cells | interferon alpha | CD cells | Life Sciences & Biomedicine | Science & Technology | Virology | Interferon-alpha - pharmacology | Antiviral Agents - pharmacology | Cytokines - metabolism | HIV Seropositivity | HIV-1 - drug effects | Killer Cells, Natural - virology | Lymphocyte Activation | HIV Infections - virology | Humans | Viremia - drug therapy | Virus Latency - drug effects | Case-Control Studies | HIV Infections - immunology | HIV-1 - immunology | Viremia - virology | CD8-Positive T-Lymphocytes - virology | CD8-Positive T-Lymphocytes - drug effects | Killer Cells, Natural - immunology | HIV Infections - drug therapy | Viremia - immunology | Killer Cells, Natural - drug effects | CD8-Positive T-Lymphocytes - immunology | Virus Latency - immunology | Cell Degranulation - drug effects | Index Medicus
Journal Article
The EMBO journal, ISSN 0261-4189, 03/2013, Volume 32, Issue 6, pp. 816 - 828
interferon regulatory factor 3 | dendritic cells | I kappa B Kinase alpha | T‐cell priming | T-cell priming | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Listeria monocytogenes - immunology | I-kappa B Kinase - physiology | Adaptive Immunity - genetics | Cell Differentiation - genetics | I-kappa B Kinase - metabolism | Listeriosis - immunology | Dendritic Cells - metabolism | Infection - immunology | Listeriosis - genetics | Mice, Inbred C57BL | Cells, Cultured | Mice, Transgenic | Inflammation - immunology | I-kappa B Kinase - genetics | Cell Differentiation - immunology | Infection - genetics | Listeria monocytogenes - pathogenicity | Animals | Adoptive Transfer - methods | Inflammation - genetics | Mice | Dendritic Cells - transplantation | Autoimmune diseases | Bacteria | Cells | Index Medicus
Journal Article
5.
Full Text
Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alpha
Clinical immunology (Orlando, Fla.), ISSN 1521-6616, 2012, Volume 143, Issue 3, pp. 210 - 221
Allergy and Immunology | Pin1 | TLR | IRF | Virome | pDC | Proteasome | PDC | Life Sciences & Biomedicine | Immunology | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Dendritic Cells - immunology | Humans | Interferon-alpha - antagonists & inhibitors | Toll-Like Receptors - immunology | Interferon Regulatory Factors - genetics | Clinical Trials as Topic | Interferon-alpha - immunology | Interferon Regulatory Factors - immunology | Animals | Interferon-alpha - genetics | Lupus Erythematosus, Systemic - genetics | Toll-Like Receptors - genetics | Lupus Erythematosus, Systemic - drug therapy | Lupus Erythematosus, Systemic - immunology | Toll-Like Receptors - antagonists & inhibitors | Dendritic Cells - drug effects | Mice | Lupus | Care and treatment | Systemic lupus erythematosus | Monoclonal antibodies | Lupus erythematosus | Interferon | Biological response modifiers | Index Medicus | Translation | Clinical trials | Genomes | Vaccines | Risk factors | Side effects | Reviews | Toll-like receptors | alpha -Interferon | Autoimmune diseases | Pharmaceuticals | virome | interferonopathies | proteasome | STAT | JAK
Journal Article
Journal of neurochemistry, ISSN 0022-3042, 01/2020, Volume 152, Issue 1, pp. 61 - 71
Nurr1 | CD4 + T cells | alpha synuclein | multiple sclerosis | Biochemistry & Molecular Biology | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cell proliferation | Antigens | Parkinson's disease | Cytokines | Neurodegenerative diseases | Myelin | Interleukin | Inflammatory response | Lymphocytes T | siRNA | Inflammation | Synuclein | Nuclear receptors | Experimental allergic encephalomyelitis | CD4 antigen | Nurr1 protein | Lymphocytes | Interferon | Movement disorders | Index Medicus
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 01/2016, Volume 75, Issue 1, pp. 196 - 202
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Glucocorticoids - administration & dosage | Antibodies, Monoclonal, Humanized - therapeutic use | Injections, Intravenous | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Immunologic Factors - administration & dosage | Male | Treatment Outcome | Biomarkers - blood | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Lupus Erythematosus, Systemic - drug therapy | Lupus Erythematosus, Systemic - immunology | Adult | Female | Immunologic Factors - adverse effects | Drug Therapy, Combination | Immunologic Factors - therapeutic use | Monoclonal antibodies | Care and treatment | Systemic lupus erythematosus | Research | Health aspects | Interferon alpha | Index Medicus
Journal Article
Environmental science & technology, ISSN 0013-936X, 04/2013, Volume 47, Issue 7, pp. 3378 - 3385
Engineering | Engineering, Environmental | Life Sciences & Biomedicine | Technology | Environmental Sciences & Ecology | Science & Technology | Environmental Sciences | Fundamental and applied biological sciences. Psychology | Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains | Biological and medical sciences | Microbiology |